Study: Arthritis treatment can protect against immune gland disease

In a Swedish study, it was reported that there was a possible relationship between anti -rheumatoid immune medicines used in the treatment of rheumatoid arthritis, and the prevention of self -immune thyroid diseases. The study, conducted by researchers from the Swedish “Carolinska” institute, indicated that this observation could indicate a new direction in investigating the benefits of these drugs, which exceeds arthritis, and it may extend to reducing the risk of self -immune thyroid disease. The amended medication of immunity, including anti -rheumatoid biological agents, is medicines used to adjust or regulate the activity of the immune system, and are mainly used in the treatment of auto -immune diseases such as rheumatoid arthritis and other inflammatory cases, where the immune system is incorrectly attacked by the tissue. It is known that patients with rheumatoid arthritis are increasingly risking auto -immune thyroid disease such as Hashimoto and Griffs. While patients with rheumatoid arthritis are usually treated with immunosuppressive drugs affecting the immune system, these medicines are rarely used in self -immune thyroid diseases. Instead, these patients with the thyroid hormone are treated to compensate for changes in the natural thyroid function that are accompanied by self -immune thyroid disease. Data from more than 13 thousand patients and researchers in the present study published in the journal “International Medicine” wanted to verify or reduce immune medicine that reduces inflammation in the joints of patients with rheumatoid arthritis, can also reduce the risk of self -immune thyroid disease. Previous studies conducted on mice indicate that the immune treatments used to treat rheumatoid arthritis can reduce inflammation of the thyroid gland, but the knowledge or this effect also applies to humans. The researchers used data between 2006 and 2018 on more than 13,000 patients with rheumatoid arthritis, in addition to data of more than 63,000 in a monitoring group that does not suffer from rheumatoid arthritis. The most obvious decrease was seen in the risk of selfillness of self -immunological thyroid disease in patients with rheumatoid arthritis, and they were treated with immunosuppressants. Among these patients, the risk of auto -immune thyroid disease was 46% less compared to the control group. These results are supported by the hypothesis that certain types of immune suppressant drugs can have a preventative effect on self -immune thyroid diseases. The effects of the study emphasize the importance of examining the various therapeutic abilities, and can redefine the extent of immune suppressing medication in combating auto -immune diseases to exceed their current applications in the treatment of rheumatoid arthritis.